Skip to content
Erman Akkus路 @Erman_Akkus 路 X路路 1 day agoScore70
Body

馃殌Presidential #ESMO26
HARMONi-GI1 in advanced BTC

馃煝Ivonescimab-GemCis vs Durva-Gemcis

鉁卪OS: 14.9 vs. 12.1 months; HR 0.75, 95% CI 0.61-0.92, P = 0.0031
鉁卪PFS: 8.4 vs. 5.8 months, HR 0.61, 95% CI 0.51-0.72, P <0.0001
鉁匫RR: 53.8 % vs. 32.5 % (P <0.0001)

#cancer #oncology #MedX @OncoAlert #biliary #cholangiocarcinoma #gallbladder

27 views 路 0 likes 路 0 reposts 路 0 replies

Source: Erman Akkus 路 x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website鈥檚 feedback page.